The Economic Impact of Atrial Fibrillation in the US and the Opportunities to Improve Care

Wednesday, December 7th, 2016 | 11:00am - 12:00pm CT 

This presentation provides a review of the growing incidence and economic impact of Atrial Fibrillation in the United States. The discussion will include identification of key opportunities to improve clinical care and the potential economic impact of new Medtronic technologies in the Atrial Fibrillation space.

Learning Objectives: 

  • The burden and economics of Atrial Fibrillation on US Hospitals
  • The opportunities to improve clinical care and outcomes in Atrial Fibrillation care
  • The economic impact of Cryoballoon technology in the treatment of Atrial Fibrillation

Presenters: 

 Mark Burton, Medtronic, Director of Market Access and Customer Economics in the Cardiac Rhythm and Heart Failure Management Division.png